前列腺素E1在闭塞性动脉疾病病例中的临床应用。
Clinical application of prostaglandin E1 in cases of occlusive arterial disease.
作者信息
Mishima Y
出版信息
Adv Prostaglandin Thromboxane Leukot Res. 1985;15:547-8.
PMID:2936166
Abstract
For the present time, intraarterial infusion of PGE1 is the treatment of choice for impending gangrene. But because of its technical difficulties and unpleasant side effects, mentioned earlier, intravenous administration of PGE1 should be considered in some cases.
摘要
目前，动脉内输注前列腺素E1是即将发生坏疽时的首选治疗方法。但由于其技术难度和前文提到的不良副作用，在某些情况下应考虑静脉注射前列腺素E1。
相似文献
1
Clinical application of prostaglandin E1 in cases of occlusive arterial disease.前列腺素E1在闭塞性动脉疾病病例中的临床应用。
Adv Prostaglandin Thromboxane Leukot Res. 1985;15:547-8.
2
3
Intraarterial prostaglandine E1 in arterial occlusive disease (AOD) stages III and IV.动脉闭塞性疾病（AOD）III期和IV期的动脉内前列腺素E1治疗
Prog Clin Biol Res. 1987;242:439-44.
4
[Fibrinolytic activity, thrombocyte function and pharmacokinetics during intra-arterial or intravenous prostaglandin E1 infusion in patients with chronic arterial occlusive disease].
Wien Klin Wochenschr. 1988 Jul 15;100(14):477-81.
5
[Prostaglandin E1 in decreased arterial perfusion].[前列腺素E1与动脉灌注减少]
Wien Klin Wochenschr. 1988 Jul 15;100(14):490-5.
6
Clinical and haemostatic effects of intravenous prostaglandin E1 therapy in patients with peripheral arterial occlusive disease.
Panminerva Med. 1999 Mar;41(1):15-7.
7
Prostaglandin E1 in chronic arterial disease: a multicenter study.前列腺素E1治疗慢性动脉疾病：一项多中心研究。
Prog Clin Biol Res. 1987;242:445-51.
8
9
[Prostaglandin E1 in therapy of peripheral arterial occlusive disease].
Wien Klin Wochenschr. 1991;103(18):558-65.
Zotero 插件